Cefazolin plasma concentrations and urinary excretion in patients with renal impairment.
D001798:Blood Proteins / Q000032:analysis; D002511:Cephalosporins / Q000097:blood / Q000378:metabolism* / Q000652:urine; D003404:Creatinine / Q000378:metabolism; D006207:Half-Life; D006801:Humans; D007674:Kidney Diseases / Q000503:physiopathology* / Q000628:therapy; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012709:Serum Albumin / Q000032:analysis; D013440:Sulfides / Q000097:blood / Q000652:urine; D013777:Tetrazoles / Q000097:blood / Q000652:urine; D013830:Thiadiazoles / Q000097:blood / Q000652:urine; D013997:Time Factors
D001798:Blood Proteins; D002511:Cephalosporins; D012709:Serum Albumin; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles; D003404:Creatinine